AT525943A3 - Konjugat bestehend aus oder umfassend zumindest ein ß-Glucan oder ein Mannan - Google Patents

Konjugat bestehend aus oder umfassend zumindest ein ß-Glucan oder ein Mannan Download PDF

Info

Publication number
AT525943A3
AT525943A3 ATA50128/2022A AT501282022A AT525943A3 AT 525943 A3 AT525943 A3 AT 525943A3 AT 501282022 A AT501282022 A AT 501282022A AT 525943 A3 AT525943 A3 AT 525943A3
Authority
AT
Austria
Prior art keywords
mannan
glucan
conjugate consisting
cell
conjugate
Prior art date
Application number
ATA50128/2022A
Other languages
English (en)
Other versions
AT525943A2 (de
AT525943B1 (de
AT525943A9 (de
Inventor
Mandler Dr Markus
Schmidhuber Dr Sabine
Schneeberger Dr Achim
Wolber Dr Carola
Original Assignee
Tridem Bioscience Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tridem Bioscience Gmbh & Co Kg filed Critical Tridem Bioscience Gmbh & Co Kg
Priority to ATA50128/2022A priority Critical patent/AT525943B1/de
Publication of AT525943A2 publication Critical patent/AT525943A2/de
Publication of AT525943A9 publication Critical patent/AT525943A9/de
Publication of AT525943A3 publication Critical patent/AT525943A3/de
Application granted granted Critical
Publication of AT525943B1 publication Critical patent/AT525943B1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Die Erfindung betrifft die Verwendung von β -Glucanen oder Mannanen als C-Typ Lectin (CLEC) Polysaccharid-Adjuvantien für B- Zell- oder T-Zell-Epitop-Polypeptide von alpha-Synuclein.
ATA50128/2022A 2022-02-28 2022-02-28 Konjugat bestehend aus oder umfassend zumindest ein β-Glucan oder ein Mannan AT525943B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ATA50128/2022A AT525943B1 (de) 2022-02-28 2022-02-28 Konjugat bestehend aus oder umfassend zumindest ein β-Glucan oder ein Mannan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ATA50128/2022A AT525943B1 (de) 2022-02-28 2022-02-28 Konjugat bestehend aus oder umfassend zumindest ein β-Glucan oder ein Mannan

Publications (4)

Publication Number Publication Date
AT525943A2 AT525943A2 (de) 2023-09-15
AT525943A9 AT525943A9 (de) 2024-07-15
AT525943A3 true AT525943A3 (de) 2024-09-15
AT525943B1 AT525943B1 (de) 2025-02-15

Family

ID=87973322

Family Applications (1)

Application Number Title Priority Date Filing Date
ATA50128/2022A AT525943B1 (de) 2022-02-28 2022-02-28 Konjugat bestehend aus oder umfassend zumindest ein β-Glucan oder ein Mannan

Country Status (1)

Country Link
AT (1) AT525943B1 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090169549A1 (en) * 2007-12-19 2009-07-02 The Board Of Regents Of The University Of Texas System Conformational isomers of alpha-synuclein, antibodies thereto and methods of their manufacture and use
WO2009103105A2 (en) * 2008-02-22 2009-08-27 Affiris Ag Mimotope

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090169549A1 (en) * 2007-12-19 2009-07-02 The Board Of Regents Of The University Of Texas System Conformational isomers of alpha-synuclein, antibodies thereto and methods of their manufacture and use
WO2009103105A2 (en) * 2008-02-22 2009-08-27 Affiris Ag Mimotope

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies. Journal of Neuroscience 24 January 2018, 38 (4) 1000-1014; DOI: https://doi.org/10.1523/JNEUROSCI.1170-17.2017 *

Also Published As

Publication number Publication date
AT525943A2 (de) 2023-09-15
AT525943B1 (de) 2025-02-15
AT525943A9 (de) 2024-07-15

Similar Documents

Publication Publication Date Title
MA55627A (fr) Agonistes de glp-1r et leurs utilisations
MA41887A1 (fr) Dérivé de glucagon et composition comprenant un conjugué à action prolongée de celui-ci
MX2022003212A (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecificos anti-klk5/klk7 y metodos de uso.
JOP20230239A1 (ar) أجسام مضادة للنكتين-4 واستخدامتها
SA523451582B1 (ar) Ccr8 الأجسام المضادة لـ
MA55365A (fr) Procédés de production de bioconjugués de polysaccharides o-antigènes d' e. coli, compositions de ceux-ci et leurs procédés d'utilisation
EP4031159A4 (de) Implantierbare gerüste und ihre verwendung für die immuntherapie und andere verwendungen
CO2021014260A2 (es) Formas sólidas de un inhibidor de glyt1
UY39407A (es) Concentrado de cannabinoides libre de thc, método de obtención del mismo y su uso
AR122736A1 (es) Anticuerpos que reconocen sortilina
SA520420778B1 (ar) بناءات معقدة ذات وصلات مختلطة
FR3064264B1 (fr) Composition a base de tetrafluoropropene
CL2024000321A1 (es) Antagonistas de lpar1 y usos de estos
UY36431A (es) Anticuerpos monoclonales específicos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por hmpv
CL2024002184A1 (es) Olanzapina, composiciones de la misma y métodos de uso de la misma
BR112015019148A2 (pt) conjunto de unidades solares melhoradas e método de construção desse conjunto
MX2024010451A (es) Conjugado que consiste de o que comprende al menos un beta-glucano o un manano.
MX2024010450A (es) Conjugado que consiste de o que comprende al menos un beta-glucano o un manano.
EP4515157A4 (de) Dynamische akustische impedanzanpassung für kryokühler
MX2023001491A (es) Moleculas de union a gp130 y metodos de uso.
PL131245U1 (pl) Konstrukcja łączeniowa profili
CR20220090A (es) Un método para preparar ivosidenib y un intermediario del mismo
MX2021015879A (es) Peptidos restringidos.
PL427681A1 (pl) Przegroda ochronna, zwłaszcza przeciwpożarowa i/lub przeciw huraganowa
EP4276213A4 (de) Heilbare superplastische amorpheus-legierung